产品功能

应用市场介绍

The American Gastroenterological Association's Clinical Care Pathway for Nonalcoholic Steatohepatitis application is applicable to any setting where healthcare professionals care for patients with nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), including primary care, endocrinology, obesity medicine, and gastroenterology practices.

This application was developed with support from independent medical education grants provided by Intercept Pharmaceuticals, Pfizer, Allergan, and Genfit.

For more information, visit NASH.gastro.org.

收起

用户评价

立即分享产品体验

你的真实体验，为其他用户提供宝贵参考

宝石
评论可得 100 宝石
宝石随心兑换应用高级会员，每周更新 前往查看 >>
活动动态 共 0 人参加
查看更多评论